Charles Schwab Investment Management »

Avita Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $947k 69k 13.72
2023-09-30 $1.0M 69k 14.61
2023-06-30 $1.1M 68k 17.01
2023-03-31 $141k 10k 13.97
2022-12-31 $66k 10k 6.60
2022-09-30 $53k 10k 5.27
2022-06-30 $48k 10k 4.77
2022-03-31 $537k 63k 8.49
2021-12-31 $744k 62k 11.98
2021-09-30 $1.1M 62k 17.72
2021-06-30 $1.2M 61k 20.53